Skip to main content
Premium Trial:

Request an Annual Quote

BGI Extends Expiration Date for Complete Genomics Tender Offer, Gets China OK

NEW YORK (GenomeWeb News) – Complete Genomics said in a filing with the US Securities and Exchange Commission today that BGI-Shenzhen's tender offer to acquire the firm has been extended to midnight, New York City time, on Jan. 18.

The $118 million bid, which was launched in September, was scheduled to expire at midnight last Friday. Complete Genomics said that as of the close of business on Jan. 11, approximately 29.3 million shares representing around 83 percent of its outstanding common stock had been validly tendered and not withdrawn.

Complete Genomics also said in the SEC filing that the National Development and Reform Commission of the People's Republic of China had granted clearance of the proposed acquisition last Friday. The deal passed US Federal Trade Commission review last week.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.